MacroGenics Provides Update on Corporate Progress and 2020 Financial Results

NEXT STORY
TRACON Pharmaceuticals Reports Fourth Quarter and Year-End 2020 Financial Results and Provides Corporate Update
PREV STORY
Inventiva announces collaboration on non-invasive biomarkers to identify patients responding to lanifibranor with regards to NASH resolution and fibrosis improvemen
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Inventiva Announces Two Poster Presentations at the American College of Rheumatology Conference

Inventiva Announces Two Poster Presentations at the American College of Rheumatology Conference Posters to ...

author_avatar
NASDAQ Market News

Targovax initiates first clinical trial with TG02, the second product from its RAS-peptide immunotherapy platform

First patient enrolled in a Phase Ib trial in patients with locally recurrent RAS-mutated ...

author_avatar
NASDAQ Market News

PHARMAGEST INTERACTIVE : eNephro reimbursement & new Hospital partnership

Villers-lès-Nancy, 18 September 2018 - 6:00 p.m. (CET)PRESS RELEASE eNephro telemonitoring  eligibility for reimbursement ...

author_avatar
NASDAQ Market News